Pauline Hamon
Icahn School of Medicine at Mount Sinai
H-index: 15
North America-United States
Top articles of Pauline Hamon
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nature
2024/1/4
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Nature medicine
2023/6
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Nature immunology
2023/5
On the biology and therapeutic modulation of macrophages and dendritic cells in cancer
2023/4/11
Pauline Hamon
H-Index: 9
Miriam Merad
H-Index: 86
Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative …
Cancer Research
2023/4/4
Pauline Hamon
H-Index: 9
Edward Kim
H-Index: 4
Siyu Li
H-Index: 1
Elizabeth Miller
H-Index: 13
Miriam Merad
H-Index: 86
Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration
bioRxiv
2023
Pauline Hamon
H-Index: 9
Howard Lin
H-Index: 4
Zhenyu Yue
H-Index: 48
Scott J Russo
H-Index: 59
Miriam Merad
H-Index: 86
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
Immunity
2023/12/12
170P Targeting myeloid cells in non-small cell lung cancer and hepatocellular carcinoma: A window-of-opportunity trial of nivolumab with BMS-813160 (CCR2/5i) or BMS-986253 …
Immuno-Oncology and Technology
2023/12/1
541 mregDC/T helper niches enable local reactivation of CD8 T cells upon PD-1 blockade
2022/11/1
691 Immune pressure in an advanced hepatocellular cancer patient following treatment with personalized neoantigen DNA vaccine (GNOS-PV02) in combination with plasmid IL-12 …
2022/11/1
688 Prediction of HCC response to neoadjuvant immunotherapy using multiparametric magnetic resonance imaging: a preliminary study
2022/11/1
629 Neoadjuvant nivolumab combined with CCR2/5 inhibitor or anti-IL-8 antibody in non-small cell lung cancer and hepatocellular carcinoma
2022/11/1
690 Correlates of poor response to neoadjuvant anti-PD-1 therapy in hepatocellular carcinoma (HCC) include WNT pathway activation and loss of HLA expression
2022/11/1
Kunal Kundu
H-Index: 7
Wei Wang
H-Index: 14
Pauline Hamon
H-Index: 9
Myron Schwartz
H-Index: 53
Miriam Merad
H-Index: 86
Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade
BioRxiv
2022/6/26
Pauline Hamon
H-Index: 9
Nausicaa Malissen
H-Index: 9
Bruno Giotti
H-Index: 5
Zhen Zhao
H-Index: 7
Stephen Ward
H-Index: 20
Nicolas Fernandez
H-Index: 8
Jiang He
H-Index: 10
Yi Wei
H-Index: 3
Wei Wang
H-Index: 14
Namita T Gupta
H-Index: 8
Kunal Kundu
H-Index: 7
Alex Tsankov
H-Index: 22
Myron Schwartz
H-Index: 53
Miriam Merad
H-Index: 86
Determining the regulation and role of mreg DC in tumor immunity
Cancer Research
2022/6/15
The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response
Nature cancer
2022/3
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
The Lancet Gastroenterology & Hepatology
2022/3/1
The Role of TREM2 Signaling in Modulating the Macrophage Molecular Phenotype and NK Cell Antitumor Immunity in Non-small Cell Lung Cancer
2022
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy
Journal for Immunotherapy of Cancer
2022
Pauline Hamon
H-Index: 9
Characterization of molecular and spatial diversity of macrophages in hepatocellular carcinoma
Cancer Research
2021/7/1
